These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8760192)

  • 1. Proarrhythmic and antiarrhythmic actions of ion channel blockers on arrhythmias in the heart: model study.
    Chay TR
    Am J Physiol; 1996 Jul; 271(1 Pt 2):H329-56. PubMed ID: 8760192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why are some antiarrhythmic drugs proarrhythmic? Cardiac arrhythmia study by bifurcation analysis.
    Chay TR
    J Electrocardiol; 1995; 28 Suppl():191-7. PubMed ID: 8656110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proarrhythmic response to potassium channel blockade. Numerical studies of polymorphic tachyarrhythmias.
    Starmer CF; Romashko DN; Reddy RS; Zilberter YI; Starobin J; Grant AO; Krinsky VI
    Circulation; 1995 Aug; 92(3):595-605. PubMed ID: 7634474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ionic mechanisms of ischemia-related ventricular arrhythmias.
    Ducceschi V; Di Micco G; Sarubbi B; Russo B; Santangelo L; Iacono A
    Clin Cardiol; 1996 Apr; 19(4):325-31. PubMed ID: 8706374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ion channels and arrhythmias].
    Borchard U; Hafner D
    Z Kardiol; 2000; 89 Suppl 3():6-12. PubMed ID: 10810780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cardiac vulnerable period and reentrant arrhythmias: targets of anti- and proarrhythmic processes.
    Starmer CF
    Pacing Clin Electrophysiol; 1997 Feb; 20(2 Pt 2):445-54. PubMed ID: 9058848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the mechanism of action of antiarrhythmic agents.
    Grant AO
    Am Heart J; 1992 Apr; 123(4 Pt 2):1130-6. PubMed ID: 1313200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proarrhythmic response to sodium channel blockade. Theoretical model and numerical experiments.
    Starmer CF; Lastra AA; Nesterenko VV; Grant AO
    Circulation; 1991 Sep; 84(3):1364-77. PubMed ID: 1653123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proarrhythmic and antiarrhythmic effects of flecainide on nonsustained reentry around the canine atrial tricuspid ring in vitro.
    Frame LH; Rhee EK; Fei H; Luchetti W
    Pacing Clin Electrophysiol; 1991 Nov; 14(11 Pt 2):1728-34. PubMed ID: 1721165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ionic mechanisms for prolongation of refractoriness and their proarrhythmic and antiarrhythmic correlates.
    Roden DM
    Am J Cardiol; 1996 Aug; 78(4A):12-6. PubMed ID: 8780324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ischemic modulation of vulnerable period and the effects of pharmacological treatment of ischemia-induced arrhythmias: a simulation study.
    Cimponeriu A; Starmer CF; Bezerianos A
    IEEE Trans Biomed Eng; 2003 Feb; 50(2):168-77. PubMed ID: 12665030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of spiral wave reentry by K(+) channel blockade.
    Honjo H; Yamazaki M; Kamiya K; Kodama I
    Circ J; 2007; 71 Suppl A():A26-31. PubMed ID: 17587736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Termination of reentry by lidocaine in the tricuspid ring in vitro. Role of cycle-length oscillation, fast use-dependent kinetics, and fixed block.
    Fei H; Yazmajian D; Hanna MS; Frame LH
    Circ Res; 1997 Feb; 80(2):242-52. PubMed ID: 9012746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular and ionic specificity of antiarrhythmic drug actions.
    Nattel S
    J Cardiovasc Electrophysiol; 1999 Feb; 10(2):272-82. PubMed ID: 10090234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on re-entrant arrhythmias and ectopic beats in excitable tissues by bifurcation analyses.
    Chay TR; Lee YS
    J Theor Biol; 1992 Mar; 155(2):137-71. PubMed ID: 1333552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of Proarrhythmic Effects of Potassium Channel Blockers.
    Skibsbye L; Ravens U
    Card Electrophysiol Clin; 2016 Jun; 8(2):395-410. PubMed ID: 27261830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of action of antiarrhythmic drugs: from ion channel blockage to arrhythmia termination.
    Grant AO
    Pacing Clin Electrophysiol; 1997 Feb; 20(2 Pt 2):432-44. PubMed ID: 9058847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ionic determinants of functional reentry in a 2-D model of human atrial cells during simulated chronic atrial fibrillation.
    Pandit SV; Berenfeld O; Anumonwo JM; Zaritski RM; Kneller J; Nattel S; Jalife J
    Biophys J; 2005 Jun; 88(6):3806-21. PubMed ID: 15792974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subclassification of class I antiarrhythmic drugs: enhanced relevance after CAST.
    Campbell TJ
    Cardiovasc Drugs Ther; 1992 Oct; 6(5):519-28. PubMed ID: 1333276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Na(+) and K(+) channel blockade on vulnerability to and termination of fibrillation in simulated normal cardiac tissue.
    Qu Z; Weiss JN
    Am J Physiol Heart Circ Physiol; 2005 Oct; 289(4):H1692-701. PubMed ID: 15937096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.